<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"lymph node dissection":8,
"radioactive iodine":14,
"thyroid cancer":332,
"thyroidectomy":67,
"chemotherapy":16,
"safety":6,
"targeted therapy":13,
"Breast cancer":119,
"Sentinel lymph node biopsy":4,
"Pancreas":6,
"Papillary thyroid carcinoma":232,
"Prognosis":96,
"Thyroglobulin":23,
"Thyroid neoplasms":76,
"Cytology":31,
"Thyroid nodule":113,
"Ultrasonography":51,
"apoptosis":35,
"Differentiated thyroid carcinoma":29,
"Metastasis":65,
"Pediatric":8,
"Thyroiditis":12,
"Case Report":12,
"Hypothyroidism":26,
"Thyroid Hormones":7,
"Carcinoma":26,
"Neoplasms":17,
"Survival":30,
"Thyroid nodules":60,
"Fine-needle aspiration cytology":9,
"C cell hyperplasia":4,
"Cancer":82,
"Mass spectrometry imaging":3,
"Medullary thyroid carcinoma":50,
"Proteomics":8,
"Differentiated thyroid cancer":43,
"Hashimoto’s thyroiditis":5,
"Inflammation":10,
"overall survival":9,
"tyrosine kinase inhibitor":13,
"Biomarker":28,
"Colorectal cancer":12,
"Familial adenomatous polyposis":5,
"Thyroid diseases":5,
"Body mass index":5,
"Obesity":13,
"thyroid neoplasm":13,
"ultrasound":60,
"fine needle aspiration cytology":10,
"thyroid":139,
"Hyperthyroidism":13,
"Immune checkpoint inhibitors":3,
"Lung cancer":14,
"Nivolumab":9,
"Non-small cell lung cancer":4,
"Ablation techniques":5,
"High-intensity focused ultrasound ablation":4,
"Interventional ultrasonography":4,
"Ultrasound imaging":5,
"Core needle biopsy":11,
"Fine needle aspiration":26,
"Guideline":4,
"Contrast media":3,
"Treatment outcome":4,
"Thyroid ultrasound":9,
"Meta-analysis":37,
"Head and neck cancer":24,
"Radiotherapy":15,
"SPECT/CT":3,
"Distant metastases":3,
"migration":28,
"131I therapy":4,
"neuroendocrine":4,
"Prevalence":11,
"Risk factor":6,
"Thyroid carcinoma":88,
"Tumor microenvironment":7,
"Calcitonin":20,
"Thyroglobulin antibodies":3,
"Thyroid-stimulating hormone":4,
"Ovary":3,
"recurrence":37,
"thyroid gland":32,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":6,
"active surveillance":17,
"guidelines":8,
"papillary thyroid microcarcinoma":25,
"malignancy risk":3,
"Distant metastasis":5,
"FVPTC":3,
"EMT":15,
"Oncogene":4,
"Prostate cancer":7,
"TRIP13":5,
"TCGA":4,
"intraoperative nerve monitoring":3,
"thyroid surgery":11,
"risk of malignancy":7,
"salivary gland":3,
"frozen section":4,
"children":10,
"Endoscopy":6,
"Pituitary adenoma":6,
"Tumor":11,
"Positron emission tomography":5,
"risk stratification":7,
"radioiodine therapy":9,
"cancer staging":3,
"laryngeal cancer":5,
"lobectomy":6,
"total thyroidectomy":22,
"Child":4,
"Fine-needle aspiration biopsy":3,
"PET/CT":12,
"Glycolysis":11,
"Papillary thyroid cancer":99,
"Proliferation":54,
"hepatocellular carcinoma":21,
"BRAF":20,
"Thyroid tumor":5,
"anaplastic thyroid cancer":26,
"invasion":36,
"autophagy":15,
"PTC":18,
"Computer-aided diagnosis":6,
"Cancer biology":3,
"Cancer stem cells":6,
"Cell migration":5,
"Lymphoma":5,
"Thyroid disease":15,
"RET gene":3,
"RET/PTC":4,
"HCC":6,
"Disease-free survival":5,
"Lenvatinib":27,
"Hyperparathyroidism":13,
"Parathyroidectomy":6,
"Bioinformatics":3,
"differentiated thyroid cancer (DTC)":3,
"pathology":11,
"triple-negative breast cancer":3,
"medullary thyroid cancer":15,
"outcome":8,
"PI3K/AKT":4,
"AKT":5,
"RET":19,
"LncRNA":12,
"polymorphism":10,
"ablation":3,
"microcarcinoma":9,
"overtreatment":4,
"renal cell carcinoma":12,
"Radiation":11,
"Multifocal":4,
"MicroRNA":11,
"gene expression":9,
"review":6,
"Artificial intelligence":6,
"cancer treatment":4,
"Fine needle aspiration biopsy":7,
"TNBC":3,
"Cervical lymph node metastasis":3,
"Contrast-enhanced ultrasound":5,
"Elastography":9,
"differentially expressed genes (DEGs)":3,
"papillary thyroid cancer (PTC)":4,
"molecular imaging":3,
"Immunohistochemistry":40,
"long noncoding RNA":7,
"Motility":4,
"central lymph node metastasis":3,
"esophageal squamous cell carcinoma":4,
"Primary hyperparathyroidism":8,
"endocrine cancer":5,
"endocrinology":5,
"The Cancer Genome Atlas":4,
"personalized medicine":8,
"Hypertension":3,
"Insulin resistance":6,
"Metabolic syndrome":6,
"Denmark":3,
"anaplastic thyroid carcinoma":26,
"calcium and bone":3,
"VEGF":3,
"incidence":19,
"mortality":11,
"Cell proliferation":7,
"Clinical trial":5,
"Imaging":6,
"Pembrolizumab":6,
"Carcinoma, papillary":7,
"Lymphatic metastasis":8,
"Risk factors":12,
"Biopsy, fine-needle":6,
"Cytological techniques":3,
"Proto-oncogene proteins B-raf":5,
"Parathyroid glands":3,
"Iodine radioisotopes":6,
"Classification":7,
"Breast carcinoma":3,
"papillary carcinoma thyroid":5,
"BRAFV600E mutation":7,
"Pituitary":4,
"Bethesda":5,
"AMPK":5,
"PKM2":16,
"β-Catenin":8,
"epithelial–mesenchymal transition":4,
"hypoxia":4,
"Head and Neck":5,
"Follicular adenoma":4,
"Follicular carcinoma":5,
"TROP-2":3,
"Radiation therapy":5,
"Diagnostics":3,
"Surgery":31,
"Bone metastases":3,
"aerobic glycolysis":3,
"ovarian cancer":5,
"Parathyroid neoplasms":3,
"Papillary thyroid carcinoma (PTC)":12,
"Tyrosine Kinase Inhibitors":11,
"lymph node metastasis":28,
"radiomics":5,
"Angiogenesis":12,
"Fine-needle aspiration":36,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":3,
"FNA":11,
"Follicular neoplasm":5,
"NIFTP":12,
"Papillary carcinoma":23,
"Hashimoto's thyroiditis":4,
"malignant transformation":4,
"mature cystic teratoma":3,
"integrin αvβ3":6,
"tetrac":4,
"Sensitivity":3,
"SEER":4,
"nomogram":12,
"second primary malignancy":3,
"cancer incidence":5,
"Breast Neoplasms":12,
"Systematic review":11,
"complications":8,
"lateral neck dissection":6,
"BRAF V600E":11,
"Graves’ disease":4,
"Neoplasm metastasis":5,
"Metastases":6,
"thyroid hormone":7,
"Quality of life":8,
"Completion thyroidectomy":6,
"Hypoparathyroidism":8,
"Molecular marker":3,
"RAS":14,
"Thyroid cytology":6,
"Neck dissection":12,
"Differential diagnosis":3,
"Magnetic resonance imaging":5,
"ACR TI-RADS":3,
"elderly":6,
"Computed tomography":5,
"shear wave elastography":5,
"comorbidity":3,
"risk":7,
"conventional ultrasound":3,
"LINC00152":3,
"Neoadjuvant":3,
"Pancreatic cancer":5,
"Endoscopic Thyroidectomy":7,
"Robotic Thyroidectomy":4,
"18F-FDG":4,
"Vandetanib":5,
"Nodule":3,
"case-control study":3,
"cohort study":4,
"epidemiology":17,
"Malignancy":21,
"Scintigraphy":4,
"tumor growth":8,
"pregnancy":9,
"biomarkers":10,
"metabolomics":6,
"Lymph node metastases":6,
"epithelial-to-mesenchymal transition":4,
"gastric cancer":10,
"wnt/β-catenin":3,
"Efficacy":4,
"Photothermal therapy":4,
"Radioactive iodine therapy":4,
"thyroid imaging reporting and data system":6,
"Management":5,
"indeterminate cytology":7,
"indeterminate":4,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":3,
"Acromegaly":11,
"anaplastic thyroid cancer (ATC)":3,
"chemoresistance":6,
"parathyroid adenoma":8,
"esophageal cancer":3,
"therapy":4,
"heterogeneity":3,
"microRNAs":4,
"Hypocalcemia":8,
"Breast":4,
"Neuroendocrine tumor":5,
"sorafenib":15,
"Cancer survivors":3,
"extrathyroidal extension":13,
"PTEN":4,
"Triple negative breast cancer":3,
"Thyroid function":4,
"Fine-needle biopsy":3,
"Spindle cell oncocytoma":3,
"papillary microcarcinoma":3,
"Multidisciplinary team":4,
"Age":3,
"Prognostic factors":5,
"Immunotherapy":24,
"Microenvironment":3,
"Endometrial cancer":4,
"prognostic factor":5,
"oxidative stress":6,
"TNM staging":3,
"thyroid transcription factor-1":6,
"Lymphocytes":3,
"Neutrophils":3,
"Bladder cancer":6,
"Cancer risk":3,
"Polymorphisms":6,
"Cervical cancer":4,
"Melanoma":6,
"cytopathology":7,
"histopathology":13,
"miRNA":8,
"cadmium":3,
"surgical complications":4,
"oncology":9,
"Thyroid dysfunction":5,
"papillary thyroid carcinomas":4,
"Signaling pathway":3,
"UCA1":3,
"BRAF mutation":11,
"adverse effects":3,
"radioiodine-refractory differentiated thyroid carcinoma":3,
"Stat3":6,
"Thyrotropin":8,
"Osteoporosis":3,
"lymph node":12,
"Cachexia":3,
"NF-κB":6,
"Neoadjuvant chemotherapy":5,
"survival analysis":7,
"18F-FDG PET/CT":3,
"BRAFV600E":6,
"Bethesda classification":3,
"HDACs":3,
"Neoplasm":6,
"radiofrequency ablation":10,
"Parathyroid carcinoma":5,
"Follicular thyroid cancer":10,
"Pediatric thyroid cancer":4,
"Poorly differentiated thyroid cancer":6,
"Central neck dissection":5,
"Local recurrence":3,
"TIRADS":5,
"Diabetes":4,
"Diagnosis":31,
"destructive thyroiditis":3,
"eGFR":3,
"Tiroidectomía":3,
"Aggressiveness":4,
"Adiponectin":3,
"hypophysitis":3,
"lung adenocarcinoma":5,
"metastatic":3,
"papillary":7,
"immunocytochemistry":3,
"Fine-needle aspiration (FNA)":4,
"Indeterminate nodules":5,
"transoral thyroidectomy":5,
"Medullary thyroid carcinoma (MTC)":3,
"PI3K/AKT pathway":4,
"hemithyroidectomy":7,
"ThyroSeq":6,
"molecular testing":17,
"Tall cell variant":3,
"Follicular thyroid adenoma":4,
"Genetics":6,
"Next-generation sequencing":12,
"metformin":4,
"Benign thyroid disease":3,
"Risk assessment":3,
"Liver":5,
"liquid biopsy":5,
"molecular":4,
"Cisplatin":3,
"anaplastic":7,
"medullary":5,
"Chemoradiotherapy":4,
"MEN2":5,
"tumor-associated macrophages":3,
"atypia of undetermined significance/follicular lesion of undetermined significance":3,
"circular RNA":4,
"BRAF V600E mutation":7,
"TERT promoter Mutation":5,
"Recurrent laryngeal nerve":6,
"Outcomes":3,
"TOETVA":5,
"Dosimetry":5,
"Radioiodine":9,
"Levothyroxine":4,
"Afirma":5,
"Response to therapy":3,
"PD-L1":7,
"multiple endocrine neoplasia":4,
"pheochromocytoma":6,
"Radionuclide imaging":3,
"head and neck neoplasms":4,
"PD-1":5,
"exosomes":4,
"Thyroid hormone receptor":3,
"diffusion-weighted imaging":5,
"Cohort":5,
"Paraganglioma":3,
"methylation":4,
"epithelial-mesenchymal transition":10,
"autoantibodies":3,
"2019":4,
"Female":3,
"TSH":8,
"Thyroid ultrasonography":4,
"White":3,
"DNA methylation":9,
"Cyclin D1":3,
"Larynx":6,
"Screening":3,
"deep learning":5,
"squamous cell carcinoma":12,
"Bethesda system":6,
"programmed cell death 1":3,
"vitamin D":4,
"Thyroid cancer, papillary":6,
"Transcriptome":4,
"carcinogenesis":3,
"Pyruvate kinase M2":6,
"epidermal growth factor receptor":5,
"iodine":4,
"propensity score matching":3,
"long-term follow-up":4,
"Bone metastasis":3,
"colon cancer":4,
"Laparoscopic surgery":3,
"histology":4,
"Staging":4,
"neuroendocrine tumors":3,
"Lateral lymph node metastasis":3,
"Pituicytoma":3,
"Surveillance":4,
"sarcoma":3,
"Multifocality":4,
"P53":5,
"Bioinformatics analysis":5,
"Long non-coding RNA":4,
"microRNA classifier":3,
"CT":5,
"granular cell tumor":4,
"Hypocalcaemia":3,
"Oncocytic":4,
"Tumorigenesis":4,
"Cancer stem cell":3,
"oral squamous cell carcinoma":3,
"follow-up":4,
"Warburg effect":3,
"treatment":3,
"Thermal ablation":4,
"Neck":3,
"vemurafenib":3,
"Italy":5,
"Radioactive iodine ablation":3,
"Thyroglobulin antibody":3,
"Machine learning":8,
"Mutation":14,
"Diagnostic accuracy":3,
"Thyroid malignancy":7,
"molecular diagnostics":5,
"RNA-seq":5,
"Benign thyroid nodule":4,
"lymph nodes":7,
"Microwave ablation":3,
"precision medicine":3,
"Carcinoma, Medullary":3,
"Thyrotoxicosis":7,
"prevention":3,
"TERT":10,
"chromogranin A":4,
"MTC":4,
"Sunitinib":3,
"Follicular":4,
"Goiter":6,
"Kidney transplantation":3,
"Skip metastasis":4,
"extranodal extension":3,
"nomograms":3,
"oral cancer":4,
"surgical treatment":4,
"Carcinoembryonic antigen":5,
"lymphovascular invasion":3,
"thyroid papillary carcinoma":7,
"Wnt/β-catenin signaling pathway":3,
"combination therapy":3,
"Parathyroid":6,
"Incidental":3,
"Thyroid incidentaloma":4,
"infertility":3,
"follicular variant":4,
"Galectin-3":4,
"Radioiodine treatment":3,
"ceRNA":5,
"Cytokines":3,
"exosome":4,
"Complication":3,
"HMGA2":3,
"Nodular goiter":3,
"Molecular pathology":3,
"Parotid cancer":3,
"PROX1":3,
"cytoskeleton":3,
"follicular thyroid carcinoma":14,
"Poorly differentiated thyroid carcinoma":6,
"Thyroid cytopathology":4,
"Macrophages":3,
"therapeutic target":3,
"theranostics":3,
"Elasticity imaging techniques":3,
"mechanism":3,
"branchial cleft cyst":3,
"long noncoding RNA (lncRNA)":3,
"propensity score":3,
"poorly differentiated carcinoma":3,
"Vascular invasion":3,
"postoperative complications":4,
"Bilaterality":3,
"Resveratrol":4,
"immune system":3,
"Fine needle aspiration (FNA)":4,
"Childhood":6,
"cell cycle":3,
"Drug resistance":3,
"miR-206":3,
"sodium/iodide symporter":3,
"Telomerase":4,
"Epithelial to mesenchymal transition":4,
"E-cadherin":7,
"TTF-1":4,
"endometrial carcinoma":3,
"Atypia of undetermined significance":6,
"Thyroid stimulating hormone":3,
"TTF1":3,
"multiple endocrine neoplasia type 2":5,
"prophylactic thyroidectomy":3,
"Nodules":3,
"lncRNA PTCSC3":3,
"gene expression classifier":3,
"clinicopathological characteristics":4,
"Biopsy":8,
"TERT promoter":3,
"Nasopharyngeal carcinoma":4,
"endocrine tumors":3,
"epithelial-mesenchymal transition (EMT)":3,
"CASTLE":4,
"Immune-related adverse events":3,
"NIS":3,
"differentiation":4,
"tracheal reconstruction":3,
"immune checkpoints":3,
"Medullary carcinoma":3,
"Sanger sequencing":3,
"TI-RADS":4,
"Progression":5,
"Transoral":3,
"clinicopathological features":5,
"clinical trials":5,
"bioinformatic analysis":3,
"Laparoscopy":3,
"Metastatic thyroid cancer":3,
"promoter mutation":3,
"DNA repair":3,
"clinical significance":3,
"Hürthle cell carcinoma":3,
"solid tumor":3,
"epigenetics":3,
"follicular lesion of undetermined significance":3,
"adenocarcinoma":3,
"GEO":3,
"ALK":3,
"CT scan":3,
"cabozantinib":3,
"Postoperative radiotherapy":3,
"glioma":3,
"differentially expressed genes":3            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
